These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 17804733

  • 1. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K, Flechtenmacher C, Angel P, Hess J.
    Cancer Res; 2007 Sep 01; 67(17):8198-206. PubMed ID: 17804733
    [Abstract] [Full Text] [Related]

  • 2. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA.
    Cancer Res; 2005 Mar 01; 65(5):1783-91. PubMed ID: 15753375
    [Abstract] [Full Text] [Related]

  • 3. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.
    Dwivedi A, Slater SC, George SJ.
    Cardiovasc Res; 2009 Jan 01; 81(1):178-86. PubMed ID: 18852254
    [Abstract] [Full Text] [Related]

  • 4. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK, Tulchinsky EM.
    Exp Cell Res; 2007 Jan 15; 313(2):380-93. PubMed ID: 17141758
    [Abstract] [Full Text] [Related]

  • 5. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.
    Endocr Relat Cancer; 2005 Sep 15; 12(3):631-43. PubMed ID: 16172196
    [Abstract] [Full Text] [Related]

  • 6. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
    Li G, Fukunaga M, Herlyn M.
    Exp Cell Res; 2004 Jul 01; 297(1):142-51. PubMed ID: 15194432
    [Abstract] [Full Text] [Related]

  • 7. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
    Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.
    Eur Surg Res; 2007 Jul 01; 39(4):208-15. PubMed ID: 17396032
    [Abstract] [Full Text] [Related]

  • 8. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G, Chen J, Liu L, Wang Y, Li L, Qin Y, Zhou Q.
    Neoplasma; 2006 Jul 01; 53(6):530-7. PubMed ID: 17167724
    [Abstract] [Full Text] [Related]

  • 9. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
    Brouxhon S, Kyrkanides S, O'Banion MK, Johnson R, Pearce DA, Centola GM, Miller JN, McGrath KH, Erdle B, Scott G, Schneider S, VanBuskirk J, Pentland AP.
    Cancer Res; 2007 Aug 15; 67(16):7654-64. PubMed ID: 17699770
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.
    Llorens A, Rodrigo I, López-Barcons L, Gonzalez-Garrigues M, Lozano E, Vinyals A, Quintanilla M, Cano A, Fabra A.
    Lab Invest; 1998 Sep 15; 78(9):1131-42. PubMed ID: 9759657
    [Abstract] [Full Text] [Related]

  • 11. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G.
    Cancer Res; 2009 May 01; 69(9):3779-87. PubMed ID: 19383923
    [Abstract] [Full Text] [Related]

  • 12. Roles of E- and P-cadherin in the human skin.
    Furukawa F, Fujii K, Horiguchi Y, Matsuyoshi N, Fujita M, Toda K, Imamura S, Wakita H, Shirahama S, Takigawa M.
    Microsc Res Tech; 1997 Aug 15; 38(4):343-52. PubMed ID: 9297684
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K, Yoshii N, Kanzaki T, Kanekura T.
    J Dermatol; 2007 Nov 15; 34(11):746-53. PubMed ID: 17973813
    [Abstract] [Full Text] [Related]

  • 14. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes.
    Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA.
    Exp Cell Res; 2004 Apr 01; 294(2):534-49. PubMed ID: 15023540
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
    Yuan Z, Wong S, Borrelli A, Chung MA.
    Biochem Biophys Res Commun; 2007 Oct 26; 362(3):740-6. PubMed ID: 17764657
    [Abstract] [Full Text] [Related]

  • 16. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR.
    Cancer Res; 2007 Nov 15; 67(22):11064-73. PubMed ID: 18006853
    [Abstract] [Full Text] [Related]

  • 17. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S, Becke H, Hutzler P, Birchmeier W, Höfler H, Becker KF.
    Oncogene; 1999 Jul 29; 18(30):4301-12. PubMed ID: 10439038
    [Abstract] [Full Text] [Related]

  • 18. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
    Mukoyama Y, Utani A, Matsui S, Zhou S, Miyachi Y, Matsuyoshi N.
    Genes Cells; 2007 Jun 29; 12(6):787-96. PubMed ID: 17573778
    [Abstract] [Full Text] [Related]

  • 19. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.
    Johnson SK, Ramani VC, Hennings L, Haun RS.
    Cancer; 2007 May 01; 109(9):1811-20. PubMed ID: 17354228
    [Abstract] [Full Text] [Related]

  • 20. Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
    Fuchs M, Hermannstädter C, Specht K, Knyazev P, Ullrich A, Rosivatz E, Busch R, Hutzler P, Höfler H, Luber B.
    J Cell Physiol; 2005 Mar 01; 202(3):805-13. PubMed ID: 15389640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.